Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

The man's hair loss and skin papules were diagnosed as atrichia with papular lesions, not alopecia areata universalis.

Tofacitinib can be effective in treating hair loss caused by alopecia areata.

Expanding regulatory T cells may help treat alopecia areata by reducing harmful immune cells.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

Frontal fibrosing alopecia in postmenopausal women can be managed with early treatment using corticosteroids to stop hair loss.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

Anti-DFS70 antibodies can help identify nonsystemic autoimmune conditions in SLE patients.

TGF-β is found in hair follicles and may cause hair loss in alopecia areata.

Rifampicin effectively treated tufted hair folliculitis with no relapse after one year.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Frontal fibrosing alopecia often occurs after menopause, with delayed diagnosis and possible links to certain medications and conditions.

TSH levels are similar across nonscarring alopecia types, with unclear racial differences.

Belimumab may cause hair loss in lupus patients.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

Hydroxychloroquine effectively reduces symptoms of frontal fibrosing alopecia, especially in the first 6 months.

JAK1 inhibitor may effectively treat alopecia areata when TNF-α inhibitors and corticosteroids fail.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Combining anti-androgenic, anti-inflammatory, and anti-fibrotic treatments may improve hair loss outcomes, but more testing is needed.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Diphencyprone is effective for treating patchy hair loss in alopecia areata, but tacrolimus is not.

Some patients with hair loss after mild COVID-19 had positive tests for certain autoantibodies.

New treatments for hair loss show promise, especially with antiandrogens, minoxidil, and autoimmune therapies.

ILC1 cells contribute to hair loss in alopecia areata.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Early treatment and multidisciplinary care are key to managing Frontal Fibrosing Alopecia and preventing further hair loss.